Pharma Talks

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice.Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day.Key takeaways:AI should be embedded where marketers already work — content, campaigns, reportingContextual, always-on AI beats standalone tools nobody opens twiceAI won't replace pharma marketers — human context in engagement is irreplaceableBefore choosing a technology, map your end-to-end processes and define your goal first📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)

In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/marc-koolen/

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that.With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and makes a bold claim: this isn't a technology shift. It's a culture shift.Key takeaways:AI in R&D and manufacturing is already mature — commercial operations are just catching upDark factories and agentic systems show what full automation can look likeThe biggest opportunity isn't automating tasks — it's re-internalizing operational work with AIMedical and scientific affairs are best positioned to lead the way right nowThe advice that matters most: get your hands dirty and stay curious📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect:🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙️ Haider Alleg → https://www.linkedin.com/in/haideralleg/

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Yacin Marzouki, Founder and Leader of Beyond Health, to explore how AI is truly reshaping pharma marketing — and why the real transformation goes far deeper than individual pilots or content tools.Key takeaways:- AI in pharma marketing requires systemic thinking, not point solutions- Content without a delivery strategy is content that collects dust- Modular content isn't dead — it's just often implemented too early- Data hygiene and taxonomy are the boring work that makes everything else possible--📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)--🔗 Follow & Connect:🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙 Yacin Marzouki → https://www.linkedin.com/in/yacin-m-customerengagement/

Pharma has invested heavily in digital, CRM, and omnichannel — and yet the HCP engagement gap persists. In this episode, Nataliya Andreychuk talks with Mark Watson (Fractal Force) about why the problem is structural, not a failure of effort, and what it genuinely takes to close it: from fixing broken feedback loops to defining what "working" actually means at the behaviour level.Key Topics:The gap between digital investment and actual engagement resultsThe importance of foundational architecture in customer engagementThe role of feedback loops in improving HCP interactionsChallenges of content personalization and regulation in pharmaStrategic content design and journey logic in omnichannel marketingChapters00:00 Introduction to Customer Engagement Challenges02:22 Understanding the Gap in Pharma Engagement05:01 The Evolution of Customer Centricity07:56 Architecting Effective Engagement Strategies10:47 Content Creation and Regulatory Challenges13:45 Intelligent Content Design for Better Engagement16:25 Building a Feedback Loop for Success18:01 Making Engagement Real and Effective20:52 Practical Steps for Transformation23:33 Final Thoughts and RecommendationsFollow Nataliya Andreychuk and Mark in social media:https://www.linkedin.com/in/andreychuk/linkedin.com/in/markwatsonuk

In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond.👥 Guests in this episode:Rohit Khuttan — Practice Director, Everest GroupOn AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise mindset is the #1 thing that needs to change.Ruslan Horblyuk — Chief Strategy Officer, AESARAOn AI in market access, health technology assessments, trust in AI data, and whether human-in-the-loop will always be necessary.Nihar Patel — Business Development, Sun PharmaOn generative, predictive and communicative AI, breaking data silos, and the three pharma areas set for the biggest disruption.Key topics covered:Is Omnichannel really a content problem, not a channel problem?How AI is changing content production and the pharma supply chainCan we trust AI data in market access decisions?Will AI replace pharma professionals — or make them smarter?The three pharma disciplines AI will disrupt first📲 Enjoyed this episode?👉 Like, Subscribe & hit the to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at Reuters Pharma Barcelona

In this episode of Pharma Talks, Natalyia Andreychuk and Anna Shavurska explore trust in AI, especially agentic AI in pharma, the importance of women in tech, and how AI can be developed responsibly with a focus on safety, trust, and diversity.Takeaways:Trust in agentic AI and safety measures in pharmaThe importance of women in AI development and diversityTechnical approaches to secure and reliable AI, including knowledge bases and retrieval-augmented generationChapters00:00 Introduction to AI Trust and Women in Tech02:00 Understanding Agentic AI and Knowledge Base Security03:45 Ensuring Data Privacy and Trust in Pharma AI05:39 Technical Challenges in Visual and Text Generation07:35 Prompt Engineering and AI Output Precision09:50 The Importance of Women in AI Development11:38 Historical Bias and the Need for Diversity in AI12:39 Inspiration and Career Path in AI13:30 Closing Remarks and Future of Women in AI

Content Supply Chain in Pharma | Pharma TalksIn this conversation, Nataliya Andreychuk and Prasant Vijayakumar discuss the importance of the content supply chain in the pharmaceutical industry, exploring how AI is transforming content development, the relevance of modular content, and the challenges faced in ensuring effective engagement.TakeawaysContent supply chain is crucial for effective communication in pharma. AI is changing the landscape of content development. MLR processes can be streamlined to enhance efficiency. Modular content remains relevant in today's digital age. Structured data is essential for effective content management. Content velocity affects how quickly updates can be communicated. Localization is key to successful content adoption. Integration of various content formats is necessary for engagement. The future of content creation will involve more video formats. Challenging the status quo of MLR can lead to significant improvements.Chapters00:00 Introduction to Content Supply Chain in Pharma 02:18 The Role of AI in Content Development 05:11 Modular Content: Relevance and Education 07:50 Challenges in Content Structure and Data 10:26 Content Velocity and Engagement 13:03 The Future of Content Supply Chain 15:58 Localization and Infrastructure in Content Delivery 18:50 Conclusion and Future Outlook Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/

In this episode of PharmaTalks, Nataliya Andreychuk explores the rise of digital opinion leaders with pharma omnichannel and digital engagement expert Pavlo Klymenko. The conversation goes beyond influencers and traditional key opinion leaders, focusing on a new type of voice emerging naturally in open and social media. Clinicians who build trust, share practical experience, and engage peers and patients in a more open, continuous way.Takeaways Digital opinion leaders are more than just influencers; they provide credible medical information.There is a significant gap between guidelines and real-world practices in healthcare.Patients increasingly seek information from social media rather than healthcare professionals.Effective communication requires constant dialogue with clinicians.Digital opinion leaders can help fill the gap left by misinformation online.Pharma must adapt to the fast-paced changes in healthcare communication.Engagement with digital opinion leaders should be honest and transparent.The role of digital opinion leaders is essential for product launch readiness.Pharma companies need to invest time and resources in building relationships with digital opinion leaders.Creating reusable content for digital opinion leaders can enhance communication efficiency. ****Chapters 00:00 Introduction to Digital Opinion Leaders01:55 The Shift from KOLs to DOLs03:33 Understanding Pharma's Engagement with DOLs07:18 Challenges and Opportunities in Digital Engagement11:09 The Role of Medical Governance in DOL Engagement15:24 Building Effective Relationships with DOLs17:28 Practical Steps for Pharma Companies20:20 Hot or Not: Challenging the Status Quo***🔗 Links for more insights:https://viseven.com/key-opinion-leaders-in-pharma/https://viseven.com/healthcare-marketing-plan-guide/https://viseven.com/patient-engagement-in-pharma/https://viseven.com/pharma-crm/https://viseven.com/mlr-review-process-in-pharma-challenges-and-solutions/https://viseven.com/digital-transformation-in-pharma/https://viseven.com/life-sciences-industry-trends-2026/Follow Viseven, Nataliya, and Pavlo in social media: https://www.linkedin.com/company/2907491https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/pavel-klymenko-2956395/

In this episode of PharmaTalks, Nataliya Andreychuk and Nico Renner discuss the evolving landscape of pharma marketing, particularly focusing on the concept of omnichannel marketing. They explore the challenges and misconceptions surrounding omnichannel strategies, the importance of personalization versus segmentation, and the role of AI in enhancing marketing efforts. The conversation emphasizes the need for a more human touch in marketing and practical steps that pharma teams can take to improve their strategies.Nico Renner is strictly sharing is personal views and opinion as an individual, not his current employer’s position on the discussed topics.TakeawaysOmnichannel marketing is often misunderstood and overhyped.Personalization should be distinct from segmentation in marketing.The human element in marketing is crucial for effective engagement.AI can help streamline marketing processes but should focus on relevance.Pharma marketers face increasing pressure to be multifaceted experts.Segmentation can be more effective than personalization at scale.The industry needs to recalibrate its expectations from omnichannel strategies.Marketers should prioritize creating relevant content over sheer volume.The future of pharma marketing lies in understanding patient needs better.A more human touch in marketing will be increasingly valued.Chapters00:00 Introduction to Omnichannel Marketing in Pharma02:08 The Evolution of Pharma Marketing04:46 Rethinking Omnichannel: Overrated or Misunderstood?08:18 Personalization vs. Segmentation: A Misalignment?19:22 Practical Steps for Pharma's Future24:33 Hot or Not: Myths in Pharma Marketing🔗 Links for more insights:https://viseven.com/omnichannel/https://viseven.com/content-development/https://viseven.com/difference-multichannel-omnichannel-pharma-communication-many-overlooked/https://viseven.com/using-omnichannel-approach-to-achieve-better-hcp-engagement-how-does-it-work/Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Follow Viseven, Nataliya, and Paul in social media:https://www.linkedin.com/company/2907491/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/nicorenner

In this engaging conversation, Nataliya Andreychuk and Paul Tunnah discuss the evolving landscape of the pharmaceutical industry as they approach 2026. They explore the importance of digital transformation, emphasizing the need for a human-centric approach rather than a technology-first mindset. The discussion delves into the risks and rewards associated with AI in pharma, the significance of customer engagement, and the challenges of hyper-personalization versus effective segmentation. TakeawaysDigital transformation must prioritize human change over technology.AI presents both risks and rewards that need careful consideration.Customer engagement strategies should focus on building trust and connection.Segmentation is crucial for effective communication in pharma.Hyper-personalization may not be the best approach for all situations.Content quality is essential to cut through the noise in marketing.Companies should embrace a mindset of continuous evolution and adaptation.Collaboration between IT and business leaders is vital for success.The future of pharma will require a balance between technology and human insight.2026 will be a pivotal year for the pharmaceutical industry. Chapters00:00 Introduction and Year-End Reflections03:05 Digital Transformation and the Human Element05:48 AI, Risk, and Reward in Pharma08:35 Customer Engagement and the Future11:28 Navigating AI and Content Creation14:22 Hyper-Personalization vs. Segmentation17:04 Hot or Not: Industry Predictions25:52 Conclusion and Looking Ahead to 2026Watch, listen, and reflect before you plan your 2026 strategy

Discover how AI is reshaping pharma – from marketing automation to intelligent sales strategies – with our guest Fredrik Holmboe. Listen to the new Pharma Talks episode with Nataliya Andreychuk! Together, they explore how the role of the modern marketeer is evolving – from content creators to AI-driven orchestrators of omnichannel engagement. The conversation uncovers how AI in sales and marketing is reshaping daily operations, driving smarter decisions, and creating a seamless bridge between sales, marketing, and medical teams. Key topics explored in this episode: The shift from traditional marketing to AI and digital marketing approaches.How AI for sales and marketing empowers teams with predictive insights and real-time personalization.Practical examples of AI-driven sales enablement and content intelligence tools improving HCP engagement.Bridging organizational silos through data intelligence, automation, and AI for customer experience.Fredrik's ABC+ Content Excellence Framework – helping life science companies enhance digital engagement in pharma and ensure unified messaging across all channels.What the future holds for AI adoption in life science, pharma business transformation, and human-AI co-creation. Tune in to discover where creativity meets intelligence, and technology becomes the enabler of more meaningful healthcare communication! Find out more about ABC+ Content Excellence Framework: https://www.dualia.se/Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert SupportDiscover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ ***0:00 Intro03:14 The evolving role of marketers in Pharma06:09 Real-world applications of AI in marketing17:17 Bridging gaps: sales, marketing, and medical collaboration22:59 The future of marketing: orchestrating AI tools ***Follow Viseven, Nataliya, and Fredrik in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/fredrikholmboe/ ***🔗 Links for more insights:https://viseven.com/ai-data/https://viseven.com/healthcare-data-analytics/https://viseven.com/ai-medical-affairs/https://viseven.com/list-of-ai-mistakes-pharma-companies-make/

In this episode, Viseven leaders reflect on the trends shaping the pharmaceutical industry today. The discussion focuses on how digital transformation is evolving from isolated initiatives into connected systems that support real business execution. Automation and AI are no longer optional, but their value depends on how well they are integrated into existing workflows and operating models.This episode looks ahead to what’s next for pharma and life sciences, and what it takes to operationalize AI in a way that strengthens teams rather than replaces them.Key topics explored in this episode:The pharmaceutical industry is increasingly focusing on digital transformation and automation.Companies are rationalizing their systems to integrate AI more effectively.AI should be part of the core processes, not a separate entity.People and processes are crucial for successful tech integration.2026 will see a shift from AI pilots to operationalized solutions.AI will be integrated into teams to enhance productivity.The role of professionals will evolve to be more technology-savvy and cross-functional.There are challenges in balancing AI capabilities with human creativity.The industry must adapt quickly to the changing landscape of AI.Strategic thinking in the AI era requires a new approach to roles and responsibilities.***Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert SupportDiscover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ ***00:00 Introduction to Pharma Talks and Team Insights 00:56 Trends in Pharma: Digital Transformation and Automation 03:04 The Role of People and Processes in Tech Integration 05:08 Forecasting 2026: Operationalizing AI in Pharma 08:27 Challenges and Opportunities in the AI Era ***Follow Viseven, Nataliya in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/

The discussion between Nataliya and Paul serves as a reminder that the pharmaceutical industry stands at a crossroads where embracing change can lead to unprecedented opportunities. By trusting their creativity, shifting their mindsets, and focusing on quality over quantity, professionals can navigate the evolving landscape and make a lasting impact in healthcare. Key topics explored in this episode: Technological change should be embraced, not feared. Understanding customer needs is crucial for innovation. Pharma must trust its own capabilities and creativity. Predictions for the future should be bold and visionary. Quality of content is more important than quantity. Compliance should be integrated into marketing strategies. Agility in launch strategies is essential for success. A human-centric approach is vital in the age of AI. Patient-centricity must be balanced with scientific integrity. Proactive engagement with technology will shape the future of pharma. Chapters 00:00 Introduction and Overview of Pharma's Future 02:31 Embracing Change in Pharma 05:16 The Role of Customer Insights 08:00 Trusting Ourselves in Pharma Marketing 10:50 Predictions for 2026: A Visionary Outlook 13:42 Content Production and Its Evolution 16:24 The Future of Compliance in Pharma 19:12 Rethinking Launch Strategies 23:13 Embracing Agility and Evolution in Marketing 25:00 The Human Element in AI Integration 27:40 Navigating the Future of Work and Technology 29:41 Rethinking Patient-Centricity in Healthcare 33:44 Rapid Fire Insights on Industry Trends Listen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions. Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** Follow Viseven, Nataliya, and Paul in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/psimms/ ***

In this episode of Pharma Talks, Nataliya Andreychuk sits down with Yacin Marzouki for an honest conversation about why omnichannel in pharma still feels more complicated than it should be.The discussion goes beyond tools and tactics. Nataliya and Yacin explore blind spots inside pharma teams, the shift toward a true business-to-healthcare mindset, and what omnichannel maturity actually looks like in practice.Key topics explored in this episode:Omnichannel strategies in pharma need to evolve for success.Understanding HCPs' needs is crucial for effective engagement.Blind spots in data and insights hinder omnichannel effectiveness.Content strategy must be connected across all channels.Technology alone cannot solve omnichannel challenges.Local differences impact omnichannel strategies significantly.Emotional tech and empathy are the future of engagement.Chapters00:00 Introduction to Omnichannel in Pharma 02:28 Guest Introduction and Background 05:20 Identifying Blind Spots in Pharma 11:57 Understanding HCP Needs and Engagement 16:12 Maturity Levels of Omnichannel Strategies 21:04 The Role of Content and Technology 28:45 Rapid Fire Round: Hot or NotListen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions.Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ ***Follow Viseven, Nataliya, and Fredrik in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/fredrikholmboe/ ***🔗 Links for more insights:https://viseven.com/ai-data/https://viseven.com/healthcare-data-analytics/https://viseven.com/ai-medical-affairs/https://viseven.com/list-of-ai-mistakes-pharma-companies-make/

In this episode of Pharma Talks, Nataliya Andreychuk, CEO of Viseven, welcomes Alejandro Jaramillo, Head of Data Science, Insights & Analytics to discuss how AI-driven pharma decisions are redefining every aspect of the pharmaceutical industry.Together, they dive deep into how AI-driven pharmaceutical innovation is helping organizations move beyond simple dashboards toward predictive, data-led decision-making. They explore how AI in pharma enables smarter forecasting, improves drug development automation, and supports a more patient-centric approach – all while staying compliant with regulatory frameworks like HIPAA and GDPR.Key topics explored in this episode:• The shift from descriptive analytics to AI-driven decision-making in pharma.• How predictive analytics and real-world evidence enhance outcomes across the pharma digital ecosystem.• Managing ethical AI in healthcare and ensuring pharma data governance in a regulated environment.• The evolution of next-gen pharma leadership – why empathy, collaboration, and data fluency define future-ready leaders.• The role of AI personalization in simplifying engagement with HCPs and patients while maintaining compliance.Tune in now!Contact Viseven experts to elevate your healthcare marketing strategy:https://viseven.com/contact-us/***Follow Viseven, Nataliya, and Alejandro in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/aljaramillo/***Case studies mentioned by Alejandro:https://www.aktana.com/resources/case-study-nba-activation/?utm_source=chatgpt.comhttps://www.nature.com/articles/s41598-021-98387-w?utm_source=chatgpt.comhttps://www.pharmaceuticalcommerce.com/view/applying-ai-case-studies-in-pharma?utm_source=chatgpt.com https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2025.1523070/full?utm_source=chatgpt.com***🔗 Links for more insights:https://viseven.com/ai-data/https://viseven.com/healthcare-data-analytics/https://viseven.com/ai-powered-analytics-for-life-sciences-marketing/

In this episode of Pharma Talks, Nataliya Andreychuk sits down with Steve Swan, founder and CEO of The Swan Group Executive Search, to discuss how to attract and retain AI talent in pharma.As pharma integrates AI-driven healthcare solutions and adapts new business models, the demand for AI experts in pharma and life sciences AI talents is at an all-time high. Yet, pharma HR strategies face a unique challenge: competing with big tech and finance for top digital health expertise.Steve shares insights from 26+ years in executive search for biotech and pharmaceutical firms, covering:Why pharmaceutical AI talents are critical for clinical trials, R&D efficiency, and commercial strategy.How life sciences hiring challenges differ from other industries – and why mission-driven candidates often choose pharma.The rising importance of hybrid roles bridging business and IT, redefining pharmaceutical leadership.The "work in the middle" of recruitment that AI cannot replace – human judgment, empathy, and cultural fit.Future trends: from Chief AI Officer roles to evolving digital healthcare careers in pharma and biotech.Whether you're navigating AI recruitment in pharma, rethinking your pharma HR strategies, or planning your next phase of pharma industry innovation, this episode provides actionable insights into building the future pharma workforce.Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/Find out more about Swan Group: https://swangroup.net/***Follow Viseven, Nataliya, and Steve in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/swangroup/***🔗 Links for more insights:https://viseven.com/our-team/https://viseven.com/ai-data/https://viseven.com/case-studies/ai-chatbot-development/https://viseven.com/artificial-intelligence-in-pharma-industry/

In this episode of Pharma Talks, Nataliya Andreychuk once again welcomes Thomas Mrosk and Manuel Mitola, co-founders of ctcHealth, to dive deep into one of the most transformative topics in life sciences today – AI personal assistants for pharma teams.With decades of combined experience in pharma innovation, digital transformation pharma, and AI adoption, Thomas and Manuel share their perspectives on how AI agents are reshaping the way sales reps, brand managers, and marketers work in highly regulated environments. Key topics explored in this episode:• What is an AI agent? A clear breakdown of how agent AI works in the context of pharma and why it’s more than just another tool.• How to build an AI agent and how to create an AI agent: From evaluating infrastructure and compliance frameworks to piloting small, task-oriented assistants.• Practical examples of AI agent assist: Automating CRM data entry, supporting sales calls, enabling pre-call planning, and accelerating content creation.• AI agent frameworks and multi-agent systems: How combining multiple AI-powered pharma solutions can support complex processes like brand launches, campaign management, and cross-functional collaboration.• The importance of human-in-the-loop AI: Why compliance, medical review, and brand voice remain critical in AI agent development services.• Challenges and guardrails: Addressing AI hallucinations, fine-tuning models with domain knowledge, and designing intuitive AI agent software for user adoption.• Exploring the potential of AI customer service agents in pharma to enhance engagement while staying compliant.Tune in this AI healthcare podcast to explore how AI agents and humans work side by side to drive smarter, faster, and more compliant innovation!Find out more about Viseven and ctcHealth AI-driven partnership: https://viseven.com/press-release/viseven-ctchealth-partnership/Contact Viseven experts to elevate your healthcare marketing strategy:https://viseven.com/contact-us/***Follow Nataliya, Manuel, and Thomas in social media:https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/mitola/https://www.linkedin.com/in/thomas-mrosk/***🔗 Links for more insights:https://viseven.com/eva-ai-agent/https://viseven.com/ai-data/https://viseven.com/artificial-intelligence-in-pharma-industry/https://viseven.com/podcast/ai-changes-pharma/

In this episode of the Pharma Talks, Nataliya Andreychyk welcomes Katrine Bach for an inspiring conversation on how women leaders in AI and healthcare are transforming the pharma industry and shaping the future of patient care.Katrine also shares the story behind her Connected Women in AI community – a global network that empowers women driving change in data, AI, and healthcare innovation. Through this initiative, she highlights how women leaders in AI are supporting one another, advancing AI ethics, and accelerating digital solutions.This episode highlights how artificial intelligence trends and life sciences AI are redefining the way we think about healthcare disruption and the future of pharma. With a focus on women entrepreneurs in healthcare, the discussion shines a light on real examples of empowering women in pharma, their influence on data and AI strategy, patient-centric innovation, and the opportunities ahead for digital transformation.Tune in to discover how women driving change are at the heart of building smarter, more inclusive, and impactful AI for healthcare.Find out more about Connected Women In AI: https://www.connectedwomeninai.dk/Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/***Follow Viseven, Nataliya, Katrine, and Connected Women In AI in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/katrinebach/ https://www.linkedin.com/company/connected-women-in-ai/***🔗 Links for more insights:https://viseven.com/ai-data/https://viseven.com/healthcare-data-analytics/https://viseven.com/podcast/ai-changes-pharma/https://viseven.com/artificial-intelligence-in-pharma-industry/

Why should pharma companies rethink strategies that already work? In this episode of Pharma Talks, Nataliya Andreychuk is joined by Tara DeBellis to discuss why changes in the pharmaceutical industry are no longer optional but necessary for growth and sustainability. From evolving life sciences strategy to addressing regulatory changes and patient expectations, Nataliya and Tara uncover the signs that it's time to evolve. You'll learn: • How to spot early warning signs that your processes are holding back innovation. • Why pharma transformation isn't just about tools, but about smarter collaboration, omnichannel orchestration, and rethinking campaign execution. • Common myths about digital health and pharma trends, and how to separate hype from meaningful change. • Real-world lessons from healthcare marketing that highlight the risks of standing still. This episode is a must-listen for leaders navigating pharmaceutical industry changes, life sciences innovation, and healthcare change in an era of fast-moving digital disruption. Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ *** Follow Viseven, Nataliya, and Tara in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/tara-debellis-3476831bb/ *** 🔗 Links for more insights: https://viseven.com/pharma-change-management/ https://viseven.com/omnichannel/ https://viseven.com/digital-transformation-in-pharma/ https://viseven.com/7-core-components-of-successful-global-marketing-strategy/

In this episode of Pharma Talks, we take a deep dive into how AI changes the very foundation of the pharmaceutical industry. Together with Patrick Markt-Niederreite from Zero‑Click Healthcare, Nataliya explores what it truly means to move toward an AI-first pharma model – one that redefines how companies operate, communicate, and grow.More than just AI in pharma, this conversation unpacks how artificial intelligence is transforming everything from content creation to team dynamics and executive decision-making. You'll hear how AI is being used not as a bolt-on feature but as a driver of end-to-end pharma digital transformation, where workflows, roles, and success metrics are all being reimagined.Nataliya and Patrick also explore the importance of shifting from traditional output-focused KPIs to data-driven pharma decisions based on real-time feedback and decision-making automation.Throughout the episode, you'll gain insights into what using AI in pharma really looks like, how it supports AI-driven teams, and why a strong healthcare AI strategy is essential for companies aiming to compete in an increasingly digital market.Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/***0:00 Intro02:11 AI first mindset in pharma05:26 The role of AI in content creation08:22 Evolving KPIs and learning cycles11:43 Speed of testing and scaling18:03 Democratizing technology in pharma23:35 Advice for AI innovation journey***Follow Viseven, Nataliya, and Patrick in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/patrick-markt-niederreiter-41539959/***🔗 Links for more insights:https://viseven.com/ai-data/https://viseven.com/artificial-intelligence-in-pharma-industry/https://viseven.com/ai-in-life-sciences/

Explore the real story of pharma digital transformation. Hear from Paul Tunnah on how content, tech, and strategy are reshaping the pharma industry.From content transformation to the latest digital transformation trends in pharma, this episode unpacks what's working, what's evolving, and what's next.Nataliya and Paul explore the shift towards digital content transformation, how AI in pharma is accelerating pharmaceutical innovation to understand the role of pharma digital tools and regulatory digital shifts in today's healthcare landscape.Whether you're focused on healthcare technology, medical communication trends, or modernizing pharma marketing, this is your front-row seat to the future of the industry.Tune in to learn how pharma is not just going digital – but transforming for good.Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/Also, don’t miss the newly published book on CX in pharma by Paul Tunnah and Faisal Ahmed – now available here: https://www.amazon.co.uk/Prescription-Success-Delivering-Exceptional-Pharmaceutical/dp/B0FD7FBLH9***0:00 Intro02:47 The challenges of the current content supply chain05:36 Balancing creativity and compliance09:02 Europe vs. US: approaches to content production12:15 AI's role in MLR acceleration16:21 Consistency in content approval19:20 Big Pharma's role in AI transformation23:02 Collaboration for future success***Follow Viseven, Nataliya, and Paul in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/paultunnah/***🔗 Links for more insights:https://viseven.com/customer-centric-digital-transformation/https://viseven.com/digital-transformation-in-pharma/https://viseven.com/ai-data/https://viseven.com/content-development/https://viseven.com/podcast/bayer-modular-content-transformation/

Explore why pharma resists change, how to align stakeholders, and scale transformation – with Cecilia Baeza on Pharma Change Management.In this fresh episode of Pharma Talks, Nataliya and Cecilia dive deep into the human side of pharmaceutical change management: how to overcome adoption barriers and what it takes to lead a successful digital transformation in pharma.Cecilia shares real-world insights on aligning cross-functional stakeholders, boosting employee buy-in, and building internal momentum – from pilot to scale.This episode is a must-watch for pharma professionals involved in change control management in the pharmaceutical industry, digital transformation, and change management for pharma sales forces. Discover how organizational change, internal communication, and pharma culture shifts can become powerful levers for innovation.Whether you're leading a pharma transformation strategy, implementing a change management system in pharma, or working on stakeholder engagement for large-scale rollouts, this conversation offers real-world insights and actionable advice.#pharmatalks #pharmaleadership #changemanagement #organizationalchangeContact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/***Follow Viseven, Nataliya, and Cecilia in social media:https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/ceciliabaeza-castro/***🔗 Links for more insights: https://viseven.com/digital-transformation-in-pharma/ https://viseven.com/technology-consulting/ https://viseven.com/healthcare-web-development/ https://viseven.com/healthcare-data-analytics/

In this episode, we focus the complexities of scaling omnichannel strategies in pharma, especially across global markets. Join Nataliya Andreychuk and Franck Mayet, Digital Transformation and Customer Engagement Expert, as they explore the real-world challenges pharma companies face when implementing omnichannel engagement in pharma, including regional limitations, geographic agility, and cultural nuances that make a one-size-fits-all strategy ineffective.Learn how leading organizations are leveraging data-driven decision-making to enhance pharma performance tracking, improve operational efficiency, and ensure successful pharma omnichannel transformation. We also address the critical role of data transparency and collaboration between vendors and pharma companies in optimizing global campaigns and strategy execution.Whether you're refining your omnichannel strategy in pharma or navigating the complexities of multichannel engagement across markets, this episode offers valuable insights into what it really takes to transform omnichannel marketing in pharma at scale.Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/***Follow Viseven, Nataliya, and Franck in social media:https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/franckmayet/***🔗 Links for more insights: https://viseven.com/omnichannel/ https://viseven.com/pharma-professional-services/ https://viseven.com/omnichannel-kpi/ https://viseven.com/omnichannel-communication-strategy/https://viseven.com/pharmaceutical-industry-challenges/ https://viseven.com/healthcare-business-intelligence/

Explore how AI is transforming pharma marketing in this Pharma Talks podcast. Discover top AI tools delivering results and enhancing customer experience. In this episode of Pharma Talks, Nataliya Andreychuk sits down with ctcHealth experts Thomas Mrosk, Founder & Managing Director, and Manuel Mitola, Partner & Head of AI Consulting, to explore the most impactful applications of AI in pharma marketing today. Discover how artificial intelligence in pharmaceutical marketing is reshaping engagement strategies, optimizing pharma digital marketing, and enhancing customer personalization. From chatbots in healthcare to automation in pharma, our guests reveal which AI tools are delivering the best ROI and where the future of pharma AI marketing is headed. Whether you're exploring AI marketing tools, AI-driven analytics, or the role of virtual assistants in healthcare, this episode is packed with data-driven strategies and expert insights. Tune in! Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/ Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ Contact ctcHealth experts to get a free 15 mins consultation about how to adopt and use AI in Pharma Marketing: https://bit.ly/4cBCKlSFollow Nataliya, Manuel, and Thomas in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/mitola/https://www.linkedin.com/in/thomas-mrosk/🔗 Links for more insights: https://viseven.com/ai-data/ https://viseven.com/ai-enablement-services/ https://viseven.com/artificial-intelligence-in-pharma-industry/ https://viseven.com/ai-in-life-sciences/ https://viseven.com/podcast/centers-of-excellence/

Join Viseven's podcast as we explore the shift to medical content, the future of modular content & key healthcare content strategies.In this episode, Prasant Vijayakumar, Chief Strategy Officer of Viseven, joins Nataliya Andreychuk to explore the transformation of healthcare content strategy and its role in pharma content marketing strategy. The discussion highlights the industry's shift from commercial content to medical content marketing, addressing how pharmaceutical content strategy can enhance patient-centric approaches and improve health communication.Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/Follow Viseven, Nataliya, and Prasant in social media:https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/prasant-vijayakumar-5615655/🔗 Links for more insights: https://viseven.com/content-strategy-enabling/https://viseven.com/content-development/ https://viseven.com/healthcare-marketing-plan-guide/ https://viseven.com/digital-transformation-in-clinical-trials/

Is AI truly revolutionizing pharma marketing or just speeding up bad strategies? Join podcast as we explore AI's impact, compliance and future winners. Our guest, Dan Atieh, Head of eWizard, shares insights on the role of AI in pharma marketing, and how gen AI in pharma marketing is reshaping strategies. We'll dive into the recent eWizard release, discussing how AI pharma marketing is transforming marketing automation and content optimization, while also navigating regulatory challenges and pharma compliance.Contact Viseven experts to integrate AI to your healthcare content strategy: https://viseven.com/contact-us/Discover eWizard's latest updates: https://viseven.com/ewizard-march-release-2025/Follow Viseven, Nataliya, and Dan in social media:https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/danatieh/🔗 Links for more insights: https://viseven.com/ai-data/ https://viseven.com/artificial-intelligence-in-pharma-industry/ https://viseven.com/ai-in-life-sciences/ https://viseven.com/pharmaceutical-industry-challenges/ https://viseven.com/pharma-professional-services/

Is there a secret to maximizing your content production efficiency? Find out together with Joe Falcone in the new episode of Pharma Talks with Nataliya Andreychuk! Dive deep into strategies for tracking, optimizing, and scaling your content production workflow to deliver better results, faster. Whether you're part of a content production agency, managing digital content production in-house, or looking to refine your content production strategy, this episode will cover it. Joe shares insights on how to set up and monitor a Center of Excellence (CoE) within pharma organizations, the role AI plays in transforming content workflows, and how automation in content production can significantly boost efficiency. Learn about content performance KPIs, workflow optimization, and the impact of AI on modern content management practices.Follow Viseven, Nataliya, and Joe in social media: https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/joefalcone/🔗 Links for more insights: https://viseven.com/content-development/https://viseven.com/content-strategy-enabling/https://viseven.com/digital-content-production-compliance/

Join Nataliya Andreychuk and Dr. Viktoriia Tymoshenko, Senior Content Operations Manager at Bayer, for unfiltered discussion about Bayer modular transformation and its ripple effects across the organization.Is Bayer's modular content strategy a model for the industry? As Nataliya probes modular content development, Dr. Tymoshenko shares insider tips on navigating bold changes and reveals how AI technology is shaping Bayer's omnichannel marketing.Contact Viseven experts to elevate your marketing with AI: https://viseven.com/contact-us/Follow Viseven, Nataliya and Viktoriia in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/viktoriia-tymoshenko-259248b5/Find more on AI in pharma:https://viseven.com/ai-in-life-sciences/https://viseven.com/ai-enablement-services/https://viseven.com/digital-transformation-in-pharma/

In this thought-provoking episode, Krishna Venugopal, Product Manager at eWizard, and Nataliya Andreychuk, CEO and Co-founder of Viseven, dive into a dynamic conversation about the evolving role of Centers of Excellence (CoE) in today’s fast-paced business environment. Explore how organizations can harness the power of AI to build CoEs that are not only more efficient but also deeply integrated into their omnichannel strategies. Krishna and Nataliya share their unique perspectives on bridging the gap between global vision and local execution, offering a roadmap for adapting strategies to diverse markets while maintaining consistency and impact.Connect with Viseven experts: https://viseven.com/contact-us/Follow Viseven, Nataliya and Krishna in social media: https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/krishnakvenugopal/